Relationship between N-acetyltransferase 2 single-nucleotide polymorphisms and phenotype

Carcinogenesis

Volumn 31, Issue 2, 2010, Pages 326-327

  Hein, David W ^a   Millner, Lori M ^a   Leggett, Carmine S ^a   Doll, Mark A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; GENOMIC DNA; NAT2 PROTEIN, HUMAN;

ALLELE; CARCINOGEN DNA INTERACTION; CLASSIFICATION; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HOMOZYGOTE; HUMAN; LETTER; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN MODIFICATION; SINGLE NUCLEOTIDE POLYMORPHISM; DNA ADDUCT; GENETICS; NOTE;

ARYLAMINE N-ACETYLTRANSFERASE; DNA ADDUCTS; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77649226561     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp290     Document Type: Letter

References (12)

1. Agudo, A. et al. (2009) Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort. Carcinogenesis, 30, 968-9
2. Blum, M. et al. (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl Acad. Sci. USA, 88, 5237-52
3. Hein, D.W. et al. (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev., 9, 29-
4. Deitz, A.C. et al. (2004) Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. Cancer Epidemiol. Biomarkers Prev., 13, 1543-15
5. Hein, D.W. et al. (2000) Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics, 10, 291-2
6. Hein, D.W. (2006) N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene, 25, 1649-16
7. Zang, Y. et al. (2007) Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase Carcinogenesis, 28, 1665-16
8. Hein, D.W. (2009) N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. Expert Opin. Drug Metab. Toxicol., 5, 353-3
9. Zang, Y. et al. (2004) The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics, 14, 717-7
10. Bendaly, J. et al. (2009) Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations. Mutat. Res., 671, 13-19
11. van der Hel, O.L. et al. (2003) NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics, 13, 399-4
12. 1Baumgartner, K.B. et al. (2009) N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women. Toxicol Sci., 112, 211-2